Search Ontology:

ChEBI

phosphosphingolipid

Term ID

CHEBI:35786

Synonyms

phosphosphingolipids
sphingophospholipid
sphingophospholipids

Definition

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: phospholipid sphingolipid

phospholipid sphingolipid Show first 5 Terms
has subtype: (2-{[hydroxy({[(2S,3R)-3-hydroxy-2-[(1-hydroxyhexadecylidene)amino]octadecyl]oxy})phosphoryl]oxy}ethyl)trimethylazanium (2-{[hydroxy({[(2S,3R,4E)-3-hydroxy-2-[(1-hydroxyhexacosylidene)amino]octadec-4-en-1-yl]oxy})phosphoryl]oxy}ethyl)trimethylazanium (2-{[hydroxy({[(2S,3R,4E)-3-hydroxy-2-[(1-hydroxytetracosylidene)amino]octadec-4-en-1-yl]oxy})phosphoryl]oxy}ethyl)trimethylazanium (2R,3R,4R)-2-Amino-3,4-dihydroxyoctadecyl dihydrogen phosphate 15-methylhexadecasphing-4-enine-1-phosphocholine ... Show All 53 Terms

(2-{[hydroxy({[(2S,3R)-3-hydroxy-2-[(1-hydroxyhexadecylidene)amino]octadecyl]oxy})phosphoryl]oxy}ethyl)trimethylazanium (2-{[hydroxy({[(2S,3R,4E)-3-hydroxy-2-[(1-hydroxyhexacosylidene)amino]octadec-4-en-1-yl]oxy})phosphoryl]oxy}ethyl)trimethylazanium (2-{[hydroxy({[(2S,3R,4E)-3-hydroxy-2-[(1-hydroxytetracosylidene)amino]octadec-4-en-1-yl]oxy})phosphoryl]oxy}ethyl)trimethylazanium (2R,3R,4R)-2-Amino-3,4-dihydroxyoctadecyl dihydrogen phosphate 15-methylhexadecasphing-4-enine-1-phosphocholine C19 Sphingosine-1-phosphate ceramide 1-phosphate ceramide phosphoethanolamine CerP(d18:0/16:0) CerP(d18:1/26:1(17Z)) inositol phosphoceramide MIPC(d18:0/16:0) MIPC(d18:0/18:0(2OH)) MIPC(t18:0/18:0(2OH)) N-[3,4-Dihydroxy-1-({hydroxy[(2,3,4,5,6-pentahydroxycyclohexyl)oxy]phosphoryl}oxy)octadecan-2-yl]-2-hydroxyhexacosanimidic acid N-{6-[(7-nitrobenzo-2,1,3-oxadiazol-4-yl)amino]hexanoyl}sphingosylphosphocholine PE-Cer(d18:0(17Me)/16:0(3OH,15Me)) phosphoglycosphingolipid PI-Cer(d20:0/26:0) PI-Cer(t18:0/20:0(2OH)) PI-Cer(t20:0/26:0(2OH)) PI-Cer(t20:0/26:0) SM(d18:0/18:1(12Z)-2OH(9,10)) SM(d18:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) SM(d18:0/22:1(13Z)) SM(d18:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) SM(d18:0/PGE1) SM(d18:0/PGJ2) SM(d18:1/5-iso PGF2VI) SM(d18:1/6 keto-PGF1alpha) SM(d18:1/20:3(8Z,11Z,14Z)-2OH(5,6)) SM(d18:1/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) SM(d18:1/PGE2) SM(d18:1/PGF2alpha) SM(d19:0/6 keto-PGF1alpha) SM(d19:0/PGF1alpha) SM(d19:0/PGF2alpha) SM(d19:1/5-iso PGF2VI) SM(d19:1/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) SM(d19:1/PGE2) SM(d19:1/PGF1alpha) SM(d20:1/6 keto-PGF1alpha) SM(d20:1/18:1(12Z)-2OH(9,10)) SM(d20:1/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) SM(d20:1/PGE1) SM(d20:1/PGF1alpha) sphinganine-1-phosphocholine sphingoid 1-phosphate sphingomyelin sphingosine-1-phosphocholine sphingosylphosphocholine acid ZGL1 ZGL2 Show first 5 Terms

Phenotype

Phenotype resulting from phosphosphingolipid

Phenotype where environments contain phosphosphingolipid

Phenotype modified by environments containing phosphosphingolipid

Human Disease Model